Financhill
Back

Evoke Pharma Quote, Financials, Valuation and Earnings

Evoke Pharma Price Quote

$5.02
-0.07 (-8.56%)
(Updated: December 21, 2024 at 5:25 AM ET)

Evoke Pharma Key Stats

Buy
53
Evoke Pharma (EVOK) is a Buy

Day range:
$4.81 - $5.38
52-week range:
$3.54 - $14.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.56
P/B ratio:
1.72%

Volume:
43.8K
Avg. volume:
53.1K
1-year change:
-61.79%
Market cap:
$7.6M
Revenue:
$5.2M
EPS:
$-11.03

How Much Does Evoke Pharma Make?

Data Unavailable

Is Evoke Pharma Growing As A Company?

Data Unavailable

Evoke Pharma Stock Price Performance

  • Did Evoke Pharma Stock Go Up Last Month?
    Evoke Pharma share price went up by 11.62% last month
  • Did EVOK's Share Price Rise Over The Last Year?
    EVOK share price fell by -61.79% over the past 1 year

What Is Evoke Pharma 52-Week High & Low?

Evoke Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Evoke Pharma?

Data Unavailable

Is Evoke Pharma Cash Flow Positive?

Data Unavailable

Evoke Pharma Return On Invested Capital

Data Unavailable

Evoke Pharma Earnings Date & Stock Price

  • What Is Evoke Pharma's Stock Price Today?
    A single share of EVOK can be purchased today for 5.09
  • What Is Evoke Pharma’s Stock Symbol?
    Evoke Pharma trades on the nasdaq under the ticker symbol: EVOK
  • When Is Evoke Pharma’s Next Earnings Date?
    The next quarterly earnings date for Evoke Pharma is scheduled on March 14, 2025
  • When Is EVOK's next ex-dividend date?
    Evoke Pharma's next ex-dividend date is December 22, 2024
  • How To Buy Evoke Pharma Stock?
    You can buy Evoke Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Evoke Pharma Competitors

  • Who Are Evoke Pharma's Competitors?
    Below is a list of companies who compete with Evoke Pharma or are related in some way:
    • Eli Lilly and Co (LLY)
    • MEI Pharma Inc (MEIP)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Revance Therapeutics Inc (RVNC)

Evoke Pharma Dividend Yield

Data Unavailable

Evoke Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -147.37%
Revenue: 69.83% -20.96%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable